Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis.
Sarah J PughMatt WassermanMargaret MoffattSusana MarquesJuan Manuel ReyesVictor A PrietoDavy ReijndersMark H RozenbaumJuha LaineHeidi ÅhmanRaymond FarkouhPublished in: Infectious diseases and therapy (2020)
In Colombia, Finland, and The Netherlands, countries with diverse epidemiologic and population distributions, switching from a PCV10 to PCV13 program would significantly reduce the burden of IPD in all three countries in as few as 5 years.
Keyphrases